Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Trouw

Showing results (201-210 of 283) with videos related to

Pageof 29
Sort By:
JHEP Reports : Innovation in Hepatology|April 4, 2022
B-cell activating factor and IL-21 levels predict treatment response in autoimmune hepatitisMaaike Biewenga, Sebastiaan Heidt, Manon Vergunst, et al.
Rheumatology (Oxford, England)|October 3, 2017
The risk of individual autoantibodies, autoantibody combinations and levels for arthritis development in clinically suspect arthralgiaRobin M Ten Brinck, Hanna W van Steenbergen, Myrthe A M van Delft, et al.
Rheumatology (Oxford, England)|June 29, 2020
Arthritis autoantibodies in individuals without rheumatoid arthritis: follow-up data from a Dutch population-based cohort (Lifelines)Johanna Westra, Elisabeth Brouwer, Elisabeth Raveling-Eelsing, et al.
Vaccine|October 31, 1998
Induction of HIV-1 IIIb neutralizing antibodies in BALB/c mice by a chimaeric peptide consisting of a T-helper cell epitope of Semliki Forest virus and a B-cell epitope of HIVI M Fernández, H Golding, B J Benaissa-Trouw, et al.
Annals of the Rheumatic Diseases|July 28, 2017
The extensive glycosylation of the ACPA variable domain observed for ACPA-IgG is absent from ACPA-IgMAyla C Kempers, Lise Hafkenscheid, Annemarie L Dorjée, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 7, 2016
Role of Anti-Carbamylated Protein Antibodies Compared to Anti-Citrullinated Protein Antibodies in Indigenous North Americans With Rheumatoid Arthritis, Their First-Degree Relatives, and Healthy ControlsH Koppejan, L A Trouw, J Sokolove, et al.
Arthritis Research & Therapy|March 8, 2023
Geo-epidemiology of autoantibodies in rheumatoid arthritis: comparison between four ethnically diverse populationsEmma C de Moel, Leendert A Trouw, Chikashi Terao, et al.
The Journal of Rheumatology|August 16, 2015
Factor H Autoantibodies in Patients with Antiphospholipid Syndrome and ThrombosisAnna Foltyn Zadura, Ashfaque A Memon, Ljudmila Stojanovich, et al.
Arthritis Research & Therapy|July 10, 2015
Rheumatoid arthritis-associated autoantibodies in non-rheumatoid arthritis patients with mucosal inflammation: a case-control studyKoen M J Janssen, Menke J de Smit, Elisabeth Brouwer, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 31, 2018
Anti-Carbamylated Protein Antibodies and Higher Baseline Disease Activity in Rheumatoid Arthritis-A Replication Study in Three Cohorts: Comment on the Article by Truchetet et alV F A M Derksen, L A Trouw, T W J Huizinga, et al.
Pageof 29

Showing results (201-210 of 283) with videos related to

Sort By:
Pageof 29
JHEP Reports : Innovation in Hepatology|April 4, 2022
B-cell activating factor and IL-21 levels predict treatment response in autoimmune hepatitisMaaike Biewenga, Sebastiaan Heidt, Manon Vergunst, et al.
Rheumatology (Oxford, England)|October 3, 2017
The risk of individual autoantibodies, autoantibody combinations and levels for arthritis development in clinically suspect arthralgiaRobin M Ten Brinck, Hanna W van Steenbergen, Myrthe A M van Delft, et al.
Rheumatology (Oxford, England)|June 29, 2020
Arthritis autoantibodies in individuals without rheumatoid arthritis: follow-up data from a Dutch population-based cohort (Lifelines)Johanna Westra, Elisabeth Brouwer, Elisabeth Raveling-Eelsing, et al.
Vaccine|October 31, 1998
Induction of HIV-1 IIIb neutralizing antibodies in BALB/c mice by a chimaeric peptide consisting of a T-helper cell epitope of Semliki Forest virus and a B-cell epitope of HIVI M Fernández, H Golding, B J Benaissa-Trouw, et al.
Annals of the Rheumatic Diseases|July 28, 2017
The extensive glycosylation of the ACPA variable domain observed for ACPA-IgG is absent from ACPA-IgMAyla C Kempers, Lise Hafkenscheid, Annemarie L Dorjée, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 7, 2016
Role of Anti-Carbamylated Protein Antibodies Compared to Anti-Citrullinated Protein Antibodies in Indigenous North Americans With Rheumatoid Arthritis, Their First-Degree Relatives, and Healthy ControlsH Koppejan, L A Trouw, J Sokolove, et al.
Arthritis Research & Therapy|March 8, 2023
Geo-epidemiology of autoantibodies in rheumatoid arthritis: comparison between four ethnically diverse populationsEmma C de Moel, Leendert A Trouw, Chikashi Terao, et al.
The Journal of Rheumatology|August 16, 2015
Factor H Autoantibodies in Patients with Antiphospholipid Syndrome and ThrombosisAnna Foltyn Zadura, Ashfaque A Memon, Ljudmila Stojanovich, et al.
Arthritis Research & Therapy|July 10, 2015
Rheumatoid arthritis-associated autoantibodies in non-rheumatoid arthritis patients with mucosal inflammation: a case-control studyKoen M J Janssen, Menke J de Smit, Elisabeth Brouwer, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 31, 2018
Anti-Carbamylated Protein Antibodies and Higher Baseline Disease Activity in Rheumatoid Arthritis-A Replication Study in Three Cohorts: Comment on the Article by Truchetet et alV F A M Derksen, L A Trouw, T W J Huizinga, et al.
Pageof 29